Clinical Trials · NCT02367014
Safety, Tolerability, and Efficacy of MTP-131 for the Treatment of Mitochondrial Myopathy
- Phase
- Phase 1/Phase 2
- Recruitment status
- Completed
- Sponsor
- Stealth BioTherapeutics Inc.
- Enrollment
- 36
- Start date
- Feb 2015
- Locations
- 4 sites, United States
- Primary endpoint
- Change in Distance Walked (Meters) on the 6-minute Walk Test (6MWT)